Global Dermal Fillers and Botulinum Toxin Supply, Demand and Key Producers, 2024-2030

Global Dermal Fillers and Botulinum Toxin Supply, Demand and Key Producers, 2024-2030

Page: 161

Published Date: 24 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Dermal Fillers and Botulinum Toxin market size is expected to reach $ 26020 million by 2030, rising at a market growth of 9.9% CAGR during the forecast period (2024-2030).

Global key players of dermal fillers and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top three players hold a share about 72%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 21% and 18%, separately.

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

This report studies the global Dermal Fillers and Botulinum Toxin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dermal Fillers and Botulinum Toxin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dermal Fillers and Botulinum Toxin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Dermal Fillers and Botulinum Toxin total production and demand, 2019-2030, (K Units)
Global Dermal Fillers and Botulinum Toxin total production value, 2019-2030, (USD Million)
Global Dermal Fillers and Botulinum Toxin production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Dermal Fillers and Botulinum Toxin consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Dermal Fillers and Botulinum Toxin domestic production, consumption, key domestic manufacturers and share
Global Dermal Fillers and Botulinum Toxin production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Dermal Fillers and Botulinum Toxin production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Dermal Fillers and Botulinum Toxin production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Dermal Fillers and Botulinum Toxin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, Hugel, Croma-Pharma, Beijing IMEIK and Bloomage Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dermal Fillers and Botulinum Toxin market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Dermal Fillers and Botulinum Toxin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Dermal Fillers and Botulinum Toxin Market, Segmentation by Type
Dermal Fillers
Botulinum Toxin

Global Dermal Fillers and Botulinum Toxin Market, Segmentation by Application
Cosmetic
Medical

Companies Profiled:
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA

Key Questions Answered
1. How big is the global Dermal Fillers and Botulinum Toxin market?
2. What is the demand of the global Dermal Fillers and Botulinum Toxin market?
3. What is the year over year growth of the global Dermal Fillers and Botulinum Toxin market?
4. What is the production and production value of the global Dermal Fillers and Botulinum Toxin market?
5. Who are the key producers in the global Dermal Fillers and Botulinum Toxin market?
btl

Table of Contents

1 Supply Summary
1.1 Dermal Fillers and Botulinum Toxin Introduction
1.2 World Dermal Fillers and Botulinum Toxin Supply & Forecast
1.2.1 World Dermal Fillers and Botulinum Toxin Production Value (2019 & 2023 & 2030)
1.2.2 World Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.2.3 World Dermal Fillers and Botulinum Toxin Pricing Trends (2019-2030)
1.3 World Dermal Fillers and Botulinum Toxin Production by Region (Based on Production Site)
1.3.1 World Dermal Fillers and Botulinum Toxin Production Value by Region (2019-2030)
1.3.2 World Dermal Fillers and Botulinum Toxin Production by Region (2019-2030)
1.3.3 World Dermal Fillers and Botulinum Toxin Average Price by Region (2019-2030)
1.3.4 North America Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.5 Europe Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.6 China Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.7 China Taiwan Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.8 South Korea Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dermal Fillers and Botulinum Toxin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dermal Fillers and Botulinum Toxin Major Market Trends

2 Demand Summary
2.1 World Dermal Fillers and Botulinum Toxin Demand (2019-2030)
2.2 World Dermal Fillers and Botulinum Toxin Consumption by Region
2.2.1 World Dermal Fillers and Botulinum Toxin Consumption by Region (2019-2024)
2.2.2 World Dermal Fillers and Botulinum Toxin Consumption Forecast by Region (2025-2030)
2.3 United States Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.4 China Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.5 Europe Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.6 Japan Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.7 South Korea Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.8 ASEAN Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.9 India Dermal Fillers and Botulinum Toxin Consumption (2019-2030)

3 World Dermal Fillers and Botulinum Toxin Manufacturers Competitive Analysis
3.1 World Dermal Fillers and Botulinum Toxin Production Value by Manufacturer (2019-2024)
3.2 World Dermal Fillers and Botulinum Toxin Production by Manufacturer (2019-2024)
3.3 World Dermal Fillers and Botulinum Toxin Average Price by Manufacturer (2019-2024)
3.4 Dermal Fillers and Botulinum Toxin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dermal Fillers and Botulinum Toxin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dermal Fillers and Botulinum Toxin in 2023
3.5.3 Global Concentration Ratios (CR8) for Dermal Fillers and Botulinum Toxin in 2023
3.6 Dermal Fillers and Botulinum Toxin Market: Overall Company Footprint Analysis
3.6.1 Dermal Fillers and Botulinum Toxin Market: Region Footprint
3.6.2 Dermal Fillers and Botulinum Toxin Market: Company Product Type Footprint
3.6.3 Dermal Fillers and Botulinum Toxin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Dermal Fillers and Botulinum Toxin Production Value Comparison
4.1.1 United States VS China: Dermal Fillers and Botulinum Toxin Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Dermal Fillers and Botulinum Toxin Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Dermal Fillers and Botulinum Toxin Production Comparison
4.2.1 United States VS China: Dermal Fillers and Botulinum Toxin Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Dermal Fillers and Botulinum Toxin Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Dermal Fillers and Botulinum Toxin Consumption Comparison
4.3.1 United States VS China: Dermal Fillers and Botulinum Toxin Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Dermal Fillers and Botulinum Toxin Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Dermal Fillers and Botulinum Toxin Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value (2019-2024)
4.4.3 United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024)
4.5 China Based Dermal Fillers and Botulinum Toxin Manufacturers and Market Share
4.5.1 China Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value (2019-2024)
4.5.3 China Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024)
4.6 Rest of World Based Dermal Fillers and Botulinum Toxin Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024)

5 Market Analysis by Type
5.1 World Dermal Fillers and Botulinum Toxin Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Dermal Fillers
5.2.2 Botulinum Toxin
5.3 Market Segment by Type
5.3.1 World Dermal Fillers and Botulinum Toxin Production by Type (2019-2030)
5.3.2 World Dermal Fillers and Botulinum Toxin Production Value by Type (2019-2030)
5.3.3 World Dermal Fillers and Botulinum Toxin Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Dermal Fillers and Botulinum Toxin Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cosmetic
6.2.2 Medical
6.3 Market Segment by Application
6.3.1 World Dermal Fillers and Botulinum Toxin Production by Application (2019-2030)
6.3.2 World Dermal Fillers and Botulinum Toxin Production Value by Application (2019-2030)
6.3.3 World Dermal Fillers and Botulinum Toxin Average Price by Application (2019-2030)

7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Dermal Fillers and Botulinum Toxin Product and Services
7.1.4 AbbVie Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Galderma
7.2.1 Galderma Details
7.2.2 Galderma Major Business
7.2.3 Galderma Dermal Fillers and Botulinum Toxin Product and Services
7.2.4 Galderma Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Galderma Recent Developments/Updates
7.2.6 Galderma Competitive Strengths & Weaknesses
7.3 LG Life Sciences
7.3.1 LG Life Sciences Details
7.3.2 LG Life Sciences Major Business
7.3.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Product and Services
7.3.4 LG Life Sciences Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 LG Life Sciences Recent Developments/Updates
7.3.6 LG Life Sciences Competitive Strengths & Weaknesses
7.4 Merz
7.4.1 Merz Details
7.4.2 Merz Major Business
7.4.3 Merz Dermal Fillers and Botulinum Toxin Product and Services
7.4.4 Merz Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Merz Recent Developments/Updates
7.4.6 Merz Competitive Strengths & Weaknesses
7.5 Medytox
7.5.1 Medytox Details
7.5.2 Medytox Major Business
7.5.3 Medytox Dermal Fillers and Botulinum Toxin Product and Services
7.5.4 Medytox Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Medytox Recent Developments/Updates
7.5.6 Medytox Competitive Strengths & Weaknesses
7.6 Hugel
7.6.1 Hugel Details
7.6.2 Hugel Major Business
7.6.3 Hugel Dermal Fillers and Botulinum Toxin Product and Services
7.6.4 Hugel Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Hugel Recent Developments/Updates
7.6.6 Hugel Competitive Strengths & Weaknesses
7.7 Croma-Pharma
7.7.1 Croma-Pharma Details
7.7.2 Croma-Pharma Major Business
7.7.3 Croma-Pharma Dermal Fillers and Botulinum Toxin Product and Services
7.7.4 Croma-Pharma Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Croma-Pharma Recent Developments/Updates
7.7.6 Croma-Pharma Competitive Strengths & Weaknesses
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Details
7.8.2 Beijing IMEIK Major Business
7.8.3 Beijing IMEIK Dermal Fillers and Botulinum Toxin Product and Services
7.8.4 Beijing IMEIK Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Beijing IMEIK Recent Developments/Updates
7.8.6 Beijing IMEIK Competitive Strengths & Weaknesses
7.9 Bloomage Bio
7.9.1 Bloomage Bio Details
7.9.2 Bloomage Bio Major Business
7.9.3 Bloomage Bio Dermal Fillers and Botulinum Toxin Product and Services
7.9.4 Bloomage Bio Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Bloomage Bio Recent Developments/Updates
7.9.6 Bloomage Bio Competitive Strengths & Weaknesses
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Details
7.10.2 Elravie (Humedix) Major Business
7.10.3 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Product and Services
7.10.4 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Elravie (Humedix) Recent Developments/Updates
7.10.6 Elravie (Humedix) Competitive Strengths & Weaknesses
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Details
7.11.2 Cleviel (Pharma Research Products) Major Business
7.11.3 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Product and Services
7.11.4 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
7.11.6 Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
7.12 Haohai Biological
7.12.1 Haohai Biological Details
7.12.2 Haohai Biological Major Business
7.12.3 Haohai Biological Dermal Fillers and Botulinum Toxin Product and Services
7.12.4 Haohai Biological Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Haohai Biological Recent Developments/Updates
7.12.6 Haohai Biological Competitive Strengths & Weaknesses
7.13 Teoxane
7.13.1 Teoxane Details
7.13.2 Teoxane Major Business
7.13.3 Teoxane Dermal Fillers and Botulinum Toxin Product and Services
7.13.4 Teoxane Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Teoxane Recent Developments/Updates
7.13.6 Teoxane Competitive Strengths & Weaknesses
7.14 Sinclair
7.14.1 Sinclair Details
7.14.2 Sinclair Major Business
7.14.3 Sinclair Dermal Fillers and Botulinum Toxin Product and Services
7.14.4 Sinclair Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Sinclair Recent Developments/Updates
7.14.6 Sinclair Competitive Strengths & Weaknesses
7.15 Suneva Medical
7.15.1 Suneva Medical Details
7.15.2 Suneva Medical Major Business
7.15.3 Suneva Medical Dermal Fillers and Botulinum Toxin Product and Services
7.15.4 Suneva Medical Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Suneva Medical Recent Developments/Updates
7.15.6 Suneva Medical Competitive Strengths & Weaknesses
7.16 CG Bio
7.16.1 CG Bio Details
7.16.2 CG Bio Major Business
7.16.3 CG Bio Dermal Fillers and Botulinum Toxin Product and Services
7.16.4 CG Bio Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 CG Bio Recent Developments/Updates
7.16.6 CG Bio Competitive Strengths & Weaknesses
7.17 SciVision Biotech
7.17.1 SciVision Biotech Details
7.17.2 SciVision Biotech Major Business
7.17.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Product and Services
7.17.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 SciVision Biotech Recent Developments/Updates
7.17.6 SciVision Biotech Competitive Strengths & Weaknesses
7.18 Prollenium
7.18.1 Prollenium Details
7.18.2 Prollenium Major Business
7.18.3 Prollenium Dermal Fillers and Botulinum Toxin Product and Services
7.18.4 Prollenium Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Prollenium Recent Developments/Updates
7.18.6 Prollenium Competitive Strengths & Weaknesses
7.19 Bohus BioTech
7.19.1 Bohus BioTech Details
7.19.2 Bohus BioTech Major Business
7.19.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Product and Services
7.19.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Bohus BioTech Recent Developments/Updates
7.19.6 Bohus BioTech Competitive Strengths & Weaknesses
7.20 Caregen
7.20.1 Caregen Details
7.20.2 Caregen Major Business
7.20.3 Caregen Dermal Fillers and Botulinum Toxin Product and Services
7.20.4 Caregen Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Caregen Recent Developments/Updates
7.20.6 Caregen Competitive Strengths & Weaknesses
7.21 Ipsen
7.21.1 Ipsen Details
7.21.2 Ipsen Major Business
7.21.3 Ipsen Dermal Fillers and Botulinum Toxin Product and Services
7.21.4 Ipsen Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Ipsen Recent Developments/Updates
7.21.6 Ipsen Competitive Strengths & Weaknesses
7.22 LIBP
7.22.1 LIBP Details
7.22.2 LIBP Major Business
7.22.3 LIBP Dermal Fillers and Botulinum Toxin Product and Services
7.22.4 LIBP Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 LIBP Recent Developments/Updates
7.22.6 LIBP Competitive Strengths & Weaknesses
7.23 US World Meds
7.23.1 US World Meds Details
7.23.2 US World Meds Major Business
7.23.3 US World Meds Dermal Fillers and Botulinum Toxin Product and Services
7.23.4 US World Meds Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 US World Meds Recent Developments/Updates
7.23.6 US World Meds Competitive Strengths & Weaknesses
7.24 Daewoong
7.24.1 Daewoong Details
7.24.2 Daewoong Major Business
7.24.3 Daewoong Dermal Fillers and Botulinum Toxin Product and Services
7.24.4 Daewoong Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.24.5 Daewoong Recent Developments/Updates
7.24.6 Daewoong Competitive Strengths & Weaknesses
7.25 JETEMA
7.25.1 JETEMA Details
7.25.2 JETEMA Major Business
7.25.3 JETEMA Dermal Fillers and Botulinum Toxin Product and Services
7.25.4 JETEMA Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.25.5 JETEMA Recent Developments/Updates
7.25.6 JETEMA Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Dermal Fillers and Botulinum Toxin Industry Chain
8.2 Dermal Fillers and Botulinum Toxin Upstream Analysis
8.2.1 Dermal Fillers and Botulinum Toxin Core Raw Materials
8.2.2 Main Manufacturers of Dermal Fillers and Botulinum Toxin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Dermal Fillers and Botulinum Toxin Production Mode
8.6 Dermal Fillers and Botulinum Toxin Procurement Model
8.7 Dermal Fillers and Botulinum Toxin Industry Sales Model and Sales Channels
8.7.1 Dermal Fillers and Botulinum Toxin Sales Model
8.7.2 Dermal Fillers and Botulinum Toxin Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Dermal Fillers and Botulinum Toxin Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Dermal Fillers and Botulinum Toxin Production Value by Region (2019-2024) & (USD Million)
Table 3. World Dermal Fillers and Botulinum Toxin Production Value by Region (2025-2030) & (USD Million)
Table 4. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Region (2019-2024)
Table 5. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Region (2025-2030)
Table 6. World Dermal Fillers and Botulinum Toxin Production by Region (2019-2024) & (K Units)
Table 7. World Dermal Fillers and Botulinum Toxin Production by Region (2025-2030) & (K Units)
Table 8. World Dermal Fillers and Botulinum Toxin Production Market Share by Region (2019-2024)
Table 9. World Dermal Fillers and Botulinum Toxin Production Market Share by Region (2025-2030)
Table 10. World Dermal Fillers and Botulinum Toxin Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Dermal Fillers and Botulinum Toxin Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Dermal Fillers and Botulinum Toxin Major Market Trends
Table 13. World Dermal Fillers and Botulinum Toxin Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Dermal Fillers and Botulinum Toxin Consumption by Region (2019-2024) & (K Units)
Table 15. World Dermal Fillers and Botulinum Toxin Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Dermal Fillers and Botulinum Toxin Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Dermal Fillers and Botulinum Toxin Producers in 2023
Table 18. World Dermal Fillers and Botulinum Toxin Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Dermal Fillers and Botulinum Toxin Producers in 2023
Table 20. World Dermal Fillers and Botulinum Toxin Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Dermal Fillers and Botulinum Toxin Company Evaluation Quadrant
Table 22. World Dermal Fillers and Botulinum Toxin Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Dermal Fillers and Botulinum Toxin Production Site of Key Manufacturer
Table 24. Dermal Fillers and Botulinum Toxin Market: Company Product Type Footprint
Table 25. Dermal Fillers and Botulinum Toxin Market: Company Product Application Footprint
Table 26. Dermal Fillers and Botulinum Toxin Competitive Factors
Table 27. Dermal Fillers and Botulinum Toxin New Entrant and Capacity Expansion Plans
Table 28. Dermal Fillers and Botulinum Toxin Mergers & Acquisitions Activity
Table 29. United States VS China Dermal Fillers and Botulinum Toxin Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Dermal Fillers and Botulinum Toxin Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Dermal Fillers and Botulinum Toxin Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share (2019-2024)
Table 37. China Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share (2019-2024)
Table 42. Rest of World Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share (2019-2024)
Table 47. World Dermal Fillers and Botulinum Toxin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Dermal Fillers and Botulinum Toxin Production by Type (2019-2024) & (K Units)
Table 49. World Dermal Fillers and Botulinum Toxin Production by Type (2025-2030) & (K Units)
Table 50. World Dermal Fillers and Botulinum Toxin Production Value by Type (2019-2024) & (USD Million)
Table 51. World Dermal Fillers and Botulinum Toxin Production Value by Type (2025-2030) & (USD Million)
Table 52. World Dermal Fillers and Botulinum Toxin Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Dermal Fillers and Botulinum Toxin Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Dermal Fillers and Botulinum Toxin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Dermal Fillers and Botulinum Toxin Production by Application (2019-2024) & (K Units)
Table 56. World Dermal Fillers and Botulinum Toxin Production by Application (2025-2030) & (K Units)
Table 57. World Dermal Fillers and Botulinum Toxin Production Value by Application (2019-2024) & (USD Million)
Table 58. World Dermal Fillers and Botulinum Toxin Production Value by Application (2025-2030) & (USD Million)
Table 59. World Dermal Fillers and Botulinum Toxin Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Dermal Fillers and Botulinum Toxin Average Price by Application (2025-2030) & (USD/Unit)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Dermal Fillers and Botulinum Toxin Product and Services
Table 64. AbbVie Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Galderma Basic Information, Manufacturing Base and Competitors
Table 68. Galderma Major Business
Table 69. Galderma Dermal Fillers and Botulinum Toxin Product and Services
Table 70. Galderma Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Galderma Recent Developments/Updates
Table 72. Galderma Competitive Strengths & Weaknesses
Table 73. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 74. LG Life Sciences Major Business
Table 75. LG Life Sciences Dermal Fillers and Botulinum Toxin Product and Services
Table 76. LG Life Sciences Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. LG Life Sciences Recent Developments/Updates
Table 78. LG Life Sciences Competitive Strengths & Weaknesses
Table 79. Merz Basic Information, Manufacturing Base and Competitors
Table 80. Merz Major Business
Table 81. Merz Dermal Fillers and Botulinum Toxin Product and Services
Table 82. Merz Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Merz Recent Developments/Updates
Table 84. Merz Competitive Strengths & Weaknesses
Table 85. Medytox Basic Information, Manufacturing Base and Competitors
Table 86. Medytox Major Business
Table 87. Medytox Dermal Fillers and Botulinum Toxin Product and Services
Table 88. Medytox Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Medytox Recent Developments/Updates
Table 90. Medytox Competitive Strengths & Weaknesses
Table 91. Hugel Basic Information, Manufacturing Base and Competitors
Table 92. Hugel Major Business
Table 93. Hugel Dermal Fillers and Botulinum Toxin Product and Services
Table 94. Hugel Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Hugel Recent Developments/Updates
Table 96. Hugel Competitive Strengths & Weaknesses
Table 97. Croma-Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Croma-Pharma Major Business
Table 99. Croma-Pharma Dermal Fillers and Botulinum Toxin Product and Services
Table 100. Croma-Pharma Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Croma-Pharma Recent Developments/Updates
Table 102. Croma-Pharma Competitive Strengths & Weaknesses
Table 103. Beijing IMEIK Basic Information, Manufacturing Base and Competitors
Table 104. Beijing IMEIK Major Business
Table 105. Beijing IMEIK Dermal Fillers and Botulinum Toxin Product and Services
Table 106. Beijing IMEIK Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Beijing IMEIK Recent Developments/Updates
Table 108. Beijing IMEIK Competitive Strengths & Weaknesses
Table 109. Bloomage Bio Basic Information, Manufacturing Base and Competitors
Table 110. Bloomage Bio Major Business
Table 111. Bloomage Bio Dermal Fillers and Botulinum Toxin Product and Services
Table 112. Bloomage Bio Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Bloomage Bio Recent Developments/Updates
Table 114. Bloomage Bio Competitive Strengths & Weaknesses
Table 115. Elravie (Humedix) Basic Information, Manufacturing Base and Competitors
Table 116. Elravie (Humedix) Major Business
Table 117. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Product and Services
Table 118. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Elravie (Humedix) Recent Developments/Updates
Table 120. Elravie (Humedix) Competitive Strengths & Weaknesses
Table 121. Cleviel (Pharma Research Products) Basic Information, Manufacturing Base and Competitors
Table 122. Cleviel (Pharma Research Products) Major Business
Table 123. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Product and Services
Table 124. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Cleviel (Pharma Research Products) Recent Developments/Updates
Table 126. Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
Table 127. Haohai Biological Basic Information, Manufacturing Base and Competitors
Table 128. Haohai Biological Major Business
Table 129. Haohai Biological Dermal Fillers and Botulinum Toxin Product and Services
Table 130. Haohai Biological Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Haohai Biological Recent Developments/Updates
Table 132. Haohai Biological Competitive Strengths & Weaknesses
Table 133. Teoxane Basic Information, Manufacturing Base and Competitors
Table 134. Teoxane Major Business
Table 135. Teoxane Dermal Fillers and Botulinum Toxin Product and Services
Table 136. Teoxane Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Teoxane Recent Developments/Updates
Table 138. Teoxane Competitive Strengths & Weaknesses
Table 139. Sinclair Basic Information, Manufacturing Base and Competitors
Table 140. Sinclair Major Business
Table 141. Sinclair Dermal Fillers and Botulinum Toxin Product and Services
Table 142. Sinclair Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Sinclair Recent Developments/Updates
Table 144. Sinclair Competitive Strengths & Weaknesses
Table 145. Suneva Medical Basic Information, Manufacturing Base and Competitors
Table 146. Suneva Medical Major Business
Table 147. Suneva Medical Dermal Fillers and Botulinum Toxin Product and Services
Table 148. Suneva Medical Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Suneva Medical Recent Developments/Updates
Table 150. Suneva Medical Competitive Strengths & Weaknesses
Table 151. CG Bio Basic Information, Manufacturing Base and Competitors
Table 152. CG Bio Major Business
Table 153. CG Bio Dermal Fillers and Botulinum Toxin Product and Services
Table 154. CG Bio Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. CG Bio Recent Developments/Updates
Table 156. CG Bio Competitive Strengths & Weaknesses
Table 157. SciVision Biotech Basic Information, Manufacturing Base and Competitors
Table 158. SciVision Biotech Major Business
Table 159. SciVision Biotech Dermal Fillers and Botulinum Toxin Product and Services
Table 160. SciVision Biotech Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. SciVision Biotech Recent Developments/Updates
Table 162. SciVision Biotech Competitive Strengths & Weaknesses
Table 163. Prollenium Basic Information, Manufacturing Base and Competitors
Table 164. Prollenium Major Business
Table 165. Prollenium Dermal Fillers and Botulinum Toxin Product and Services
Table 166. Prollenium Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Prollenium Recent Developments/Updates
Table 168. Prollenium Competitive Strengths & Weaknesses
Table 169. Bohus BioTech Basic Information, Manufacturing Base and Competitors
Table 170. Bohus BioTech Major Business
Table 171. Bohus BioTech Dermal Fillers and Botulinum Toxin Product and Services
Table 172. Bohus BioTech Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Bohus BioTech Recent Developments/Updates
Table 174. Bohus BioTech Competitive Strengths & Weaknesses
Table 175. Caregen Basic Information, Manufacturing Base and Competitors
Table 176. Caregen Major Business
Table 177. Caregen Dermal Fillers and Botulinum Toxin Product and Services
Table 178. Caregen Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Caregen Recent Developments/Updates
Table 180. Caregen Competitive Strengths & Weaknesses
Table 181. Ipsen Basic Information, Manufacturing Base and Competitors
Table 182. Ipsen Major Business
Table 183. Ipsen Dermal Fillers and Botulinum Toxin Product and Services
Table 184. Ipsen Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Ipsen Recent Developments/Updates
Table 186. Ipsen Competitive Strengths & Weaknesses
Table 187. LIBP Basic Information, Manufacturing Base and Competitors
Table 188. LIBP Major Business
Table 189. LIBP Dermal Fillers and Botulinum Toxin Product and Services
Table 190. LIBP Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. LIBP Recent Developments/Updates
Table 192. LIBP Competitive Strengths & Weaknesses
Table 193. US World Meds Basic Information, Manufacturing Base and Competitors
Table 194. US World Meds Major Business
Table 195. US World Meds Dermal Fillers and Botulinum Toxin Product and Services
Table 196. US World Meds Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 197. US World Meds Recent Developments/Updates
Table 198. US World Meds Competitive Strengths & Weaknesses
Table 199. Daewoong Basic Information, Manufacturing Base and Competitors
Table 200. Daewoong Major Business
Table 201. Daewoong Dermal Fillers and Botulinum Toxin Product and Services
Table 202. Daewoong Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 203. Daewoong Recent Developments/Updates
Table 204. JETEMA Basic Information, Manufacturing Base and Competitors
Table 205. JETEMA Major Business
Table 206. JETEMA Dermal Fillers and Botulinum Toxin Product and Services
Table 207. JETEMA Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 208. Global Key Players of Dermal Fillers and Botulinum Toxin Upstream (Raw Materials)
Table 209. Dermal Fillers and Botulinum Toxin Typical Customers
Table 210. Dermal Fillers and Botulinum Toxin Typical Distributors
List of Figure
Figure 1. Dermal Fillers and Botulinum Toxin Picture
Figure 2. World Dermal Fillers and Botulinum Toxin Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Dermal Fillers and Botulinum Toxin Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 5. World Dermal Fillers and Botulinum Toxin Average Price (2019-2030) & (USD/Unit)
Figure 6. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Region (2019-2030)
Figure 7. World Dermal Fillers and Botulinum Toxin Production Market Share by Region (2019-2030)
Figure 8. North America Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 9. Europe Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 10. China Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 11. China Taiwan Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 12. South Korea Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 13. Dermal Fillers and Botulinum Toxin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 16. World Dermal Fillers and Botulinum Toxin Consumption Market Share by Region (2019-2030)
Figure 17. United States Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 18. China Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 19. Europe Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 20. Japan Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 21. South Korea Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 22. ASEAN Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 23. India Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 24. Producer Shipments of Dermal Fillers and Botulinum Toxin by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Dermal Fillers and Botulinum Toxin Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Dermal Fillers and Botulinum Toxin Markets in 2023
Figure 27. United States VS China: Dermal Fillers and Botulinum Toxin Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Dermal Fillers and Botulinum Toxin Production Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Dermal Fillers and Botulinum Toxin Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share 2023
Figure 31. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share 2023
Figure 32. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share 2023
Figure 33. World Dermal Fillers and Botulinum Toxin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 34. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Type in 2023
Figure 35. Dermal Fillers
Figure 36. Botulinum Toxin
Figure 37. World Dermal Fillers and Botulinum Toxin Production Market Share by Type (2019-2030)
Figure 38. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Type (2019-2030)
Figure 39. World Dermal Fillers and Botulinum Toxin Average Price by Type (2019-2030) & (USD/Unit)
Figure 40. World Dermal Fillers and Botulinum Toxin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Application in 2023
Figure 42. Cosmetic
Figure 43. Medical
Figure 44. World Dermal Fillers and Botulinum Toxin Production Market Share by Application (2019-2030)
Figure 45. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Application (2019-2030)
Figure 46. World Dermal Fillers and Botulinum Toxin Average Price by Application (2019-2030) & (USD/Unit)
Figure 47. Dermal Fillers and Botulinum Toxin Industry Chain
Figure 48. Dermal Fillers and Botulinum Toxin Procurement Model
Figure 49. Dermal Fillers and Botulinum Toxin Sales Model
Figure 50. Dermal Fillers and Botulinum Toxin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Dermal Fillers and Botulinum Toxin Supply, Demand and Key Producers, 2024-2030

Global Dermal Fillers and Botulinum Toxin Supply, Demand and Key Producers, 2024-2030

Page: 161

Published Date: 24 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Dermal Fillers and Botulinum Toxin market size is expected to reach $ 26020 million by 2030, rising at a market growth of 9.9% CAGR during the forecast period (2024-2030).

Global key players of dermal fillers and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top three players hold a share about 72%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 21% and 18%, separately.

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

This report studies the global Dermal Fillers and Botulinum Toxin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dermal Fillers and Botulinum Toxin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dermal Fillers and Botulinum Toxin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Dermal Fillers and Botulinum Toxin total production and demand, 2019-2030, (K Units)
Global Dermal Fillers and Botulinum Toxin total production value, 2019-2030, (USD Million)
Global Dermal Fillers and Botulinum Toxin production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Dermal Fillers and Botulinum Toxin consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Dermal Fillers and Botulinum Toxin domestic production, consumption, key domestic manufacturers and share
Global Dermal Fillers and Botulinum Toxin production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Dermal Fillers and Botulinum Toxin production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Dermal Fillers and Botulinum Toxin production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Dermal Fillers and Botulinum Toxin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, Hugel, Croma-Pharma, Beijing IMEIK and Bloomage Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dermal Fillers and Botulinum Toxin market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Dermal Fillers and Botulinum Toxin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Dermal Fillers and Botulinum Toxin Market, Segmentation by Type
Dermal Fillers
Botulinum Toxin

Global Dermal Fillers and Botulinum Toxin Market, Segmentation by Application
Cosmetic
Medical

Companies Profiled:
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA

Key Questions Answered
1. How big is the global Dermal Fillers and Botulinum Toxin market?
2. What is the demand of the global Dermal Fillers and Botulinum Toxin market?
3. What is the year over year growth of the global Dermal Fillers and Botulinum Toxin market?
4. What is the production and production value of the global Dermal Fillers and Botulinum Toxin market?
5. Who are the key producers in the global Dermal Fillers and Botulinum Toxin market?
btl

Table of Contents

1 Supply Summary
1.1 Dermal Fillers and Botulinum Toxin Introduction
1.2 World Dermal Fillers and Botulinum Toxin Supply & Forecast
1.2.1 World Dermal Fillers and Botulinum Toxin Production Value (2019 & 2023 & 2030)
1.2.2 World Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.2.3 World Dermal Fillers and Botulinum Toxin Pricing Trends (2019-2030)
1.3 World Dermal Fillers and Botulinum Toxin Production by Region (Based on Production Site)
1.3.1 World Dermal Fillers and Botulinum Toxin Production Value by Region (2019-2030)
1.3.2 World Dermal Fillers and Botulinum Toxin Production by Region (2019-2030)
1.3.3 World Dermal Fillers and Botulinum Toxin Average Price by Region (2019-2030)
1.3.4 North America Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.5 Europe Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.6 China Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.7 China Taiwan Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.3.8 South Korea Dermal Fillers and Botulinum Toxin Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dermal Fillers and Botulinum Toxin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dermal Fillers and Botulinum Toxin Major Market Trends

2 Demand Summary
2.1 World Dermal Fillers and Botulinum Toxin Demand (2019-2030)
2.2 World Dermal Fillers and Botulinum Toxin Consumption by Region
2.2.1 World Dermal Fillers and Botulinum Toxin Consumption by Region (2019-2024)
2.2.2 World Dermal Fillers and Botulinum Toxin Consumption Forecast by Region (2025-2030)
2.3 United States Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.4 China Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.5 Europe Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.6 Japan Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.7 South Korea Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.8 ASEAN Dermal Fillers and Botulinum Toxin Consumption (2019-2030)
2.9 India Dermal Fillers and Botulinum Toxin Consumption (2019-2030)

3 World Dermal Fillers and Botulinum Toxin Manufacturers Competitive Analysis
3.1 World Dermal Fillers and Botulinum Toxin Production Value by Manufacturer (2019-2024)
3.2 World Dermal Fillers and Botulinum Toxin Production by Manufacturer (2019-2024)
3.3 World Dermal Fillers and Botulinum Toxin Average Price by Manufacturer (2019-2024)
3.4 Dermal Fillers and Botulinum Toxin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dermal Fillers and Botulinum Toxin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dermal Fillers and Botulinum Toxin in 2023
3.5.3 Global Concentration Ratios (CR8) for Dermal Fillers and Botulinum Toxin in 2023
3.6 Dermal Fillers and Botulinum Toxin Market: Overall Company Footprint Analysis
3.6.1 Dermal Fillers and Botulinum Toxin Market: Region Footprint
3.6.2 Dermal Fillers and Botulinum Toxin Market: Company Product Type Footprint
3.6.3 Dermal Fillers and Botulinum Toxin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Dermal Fillers and Botulinum Toxin Production Value Comparison
4.1.1 United States VS China: Dermal Fillers and Botulinum Toxin Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Dermal Fillers and Botulinum Toxin Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Dermal Fillers and Botulinum Toxin Production Comparison
4.2.1 United States VS China: Dermal Fillers and Botulinum Toxin Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Dermal Fillers and Botulinum Toxin Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Dermal Fillers and Botulinum Toxin Consumption Comparison
4.3.1 United States VS China: Dermal Fillers and Botulinum Toxin Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Dermal Fillers and Botulinum Toxin Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Dermal Fillers and Botulinum Toxin Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value (2019-2024)
4.4.3 United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024)
4.5 China Based Dermal Fillers and Botulinum Toxin Manufacturers and Market Share
4.5.1 China Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value (2019-2024)
4.5.3 China Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024)
4.6 Rest of World Based Dermal Fillers and Botulinum Toxin Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024)

5 Market Analysis by Type
5.1 World Dermal Fillers and Botulinum Toxin Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Dermal Fillers
5.2.2 Botulinum Toxin
5.3 Market Segment by Type
5.3.1 World Dermal Fillers and Botulinum Toxin Production by Type (2019-2030)
5.3.2 World Dermal Fillers and Botulinum Toxin Production Value by Type (2019-2030)
5.3.3 World Dermal Fillers and Botulinum Toxin Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Dermal Fillers and Botulinum Toxin Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cosmetic
6.2.2 Medical
6.3 Market Segment by Application
6.3.1 World Dermal Fillers and Botulinum Toxin Production by Application (2019-2030)
6.3.2 World Dermal Fillers and Botulinum Toxin Production Value by Application (2019-2030)
6.3.3 World Dermal Fillers and Botulinum Toxin Average Price by Application (2019-2030)

7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Dermal Fillers and Botulinum Toxin Product and Services
7.1.4 AbbVie Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Galderma
7.2.1 Galderma Details
7.2.2 Galderma Major Business
7.2.3 Galderma Dermal Fillers and Botulinum Toxin Product and Services
7.2.4 Galderma Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Galderma Recent Developments/Updates
7.2.6 Galderma Competitive Strengths & Weaknesses
7.3 LG Life Sciences
7.3.1 LG Life Sciences Details
7.3.2 LG Life Sciences Major Business
7.3.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Product and Services
7.3.4 LG Life Sciences Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 LG Life Sciences Recent Developments/Updates
7.3.6 LG Life Sciences Competitive Strengths & Weaknesses
7.4 Merz
7.4.1 Merz Details
7.4.2 Merz Major Business
7.4.3 Merz Dermal Fillers and Botulinum Toxin Product and Services
7.4.4 Merz Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Merz Recent Developments/Updates
7.4.6 Merz Competitive Strengths & Weaknesses
7.5 Medytox
7.5.1 Medytox Details
7.5.2 Medytox Major Business
7.5.3 Medytox Dermal Fillers and Botulinum Toxin Product and Services
7.5.4 Medytox Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Medytox Recent Developments/Updates
7.5.6 Medytox Competitive Strengths & Weaknesses
7.6 Hugel
7.6.1 Hugel Details
7.6.2 Hugel Major Business
7.6.3 Hugel Dermal Fillers and Botulinum Toxin Product and Services
7.6.4 Hugel Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Hugel Recent Developments/Updates
7.6.6 Hugel Competitive Strengths & Weaknesses
7.7 Croma-Pharma
7.7.1 Croma-Pharma Details
7.7.2 Croma-Pharma Major Business
7.7.3 Croma-Pharma Dermal Fillers and Botulinum Toxin Product and Services
7.7.4 Croma-Pharma Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Croma-Pharma Recent Developments/Updates
7.7.6 Croma-Pharma Competitive Strengths & Weaknesses
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Details
7.8.2 Beijing IMEIK Major Business
7.8.3 Beijing IMEIK Dermal Fillers and Botulinum Toxin Product and Services
7.8.4 Beijing IMEIK Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Beijing IMEIK Recent Developments/Updates
7.8.6 Beijing IMEIK Competitive Strengths & Weaknesses
7.9 Bloomage Bio
7.9.1 Bloomage Bio Details
7.9.2 Bloomage Bio Major Business
7.9.3 Bloomage Bio Dermal Fillers and Botulinum Toxin Product and Services
7.9.4 Bloomage Bio Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Bloomage Bio Recent Developments/Updates
7.9.6 Bloomage Bio Competitive Strengths & Weaknesses
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Details
7.10.2 Elravie (Humedix) Major Business
7.10.3 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Product and Services
7.10.4 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Elravie (Humedix) Recent Developments/Updates
7.10.6 Elravie (Humedix) Competitive Strengths & Weaknesses
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Details
7.11.2 Cleviel (Pharma Research Products) Major Business
7.11.3 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Product and Services
7.11.4 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
7.11.6 Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
7.12 Haohai Biological
7.12.1 Haohai Biological Details
7.12.2 Haohai Biological Major Business
7.12.3 Haohai Biological Dermal Fillers and Botulinum Toxin Product and Services
7.12.4 Haohai Biological Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Haohai Biological Recent Developments/Updates
7.12.6 Haohai Biological Competitive Strengths & Weaknesses
7.13 Teoxane
7.13.1 Teoxane Details
7.13.2 Teoxane Major Business
7.13.3 Teoxane Dermal Fillers and Botulinum Toxin Product and Services
7.13.4 Teoxane Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Teoxane Recent Developments/Updates
7.13.6 Teoxane Competitive Strengths & Weaknesses
7.14 Sinclair
7.14.1 Sinclair Details
7.14.2 Sinclair Major Business
7.14.3 Sinclair Dermal Fillers and Botulinum Toxin Product and Services
7.14.4 Sinclair Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Sinclair Recent Developments/Updates
7.14.6 Sinclair Competitive Strengths & Weaknesses
7.15 Suneva Medical
7.15.1 Suneva Medical Details
7.15.2 Suneva Medical Major Business
7.15.3 Suneva Medical Dermal Fillers and Botulinum Toxin Product and Services
7.15.4 Suneva Medical Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Suneva Medical Recent Developments/Updates
7.15.6 Suneva Medical Competitive Strengths & Weaknesses
7.16 CG Bio
7.16.1 CG Bio Details
7.16.2 CG Bio Major Business
7.16.3 CG Bio Dermal Fillers and Botulinum Toxin Product and Services
7.16.4 CG Bio Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 CG Bio Recent Developments/Updates
7.16.6 CG Bio Competitive Strengths & Weaknesses
7.17 SciVision Biotech
7.17.1 SciVision Biotech Details
7.17.2 SciVision Biotech Major Business
7.17.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Product and Services
7.17.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 SciVision Biotech Recent Developments/Updates
7.17.6 SciVision Biotech Competitive Strengths & Weaknesses
7.18 Prollenium
7.18.1 Prollenium Details
7.18.2 Prollenium Major Business
7.18.3 Prollenium Dermal Fillers and Botulinum Toxin Product and Services
7.18.4 Prollenium Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Prollenium Recent Developments/Updates
7.18.6 Prollenium Competitive Strengths & Weaknesses
7.19 Bohus BioTech
7.19.1 Bohus BioTech Details
7.19.2 Bohus BioTech Major Business
7.19.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Product and Services
7.19.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Bohus BioTech Recent Developments/Updates
7.19.6 Bohus BioTech Competitive Strengths & Weaknesses
7.20 Caregen
7.20.1 Caregen Details
7.20.2 Caregen Major Business
7.20.3 Caregen Dermal Fillers and Botulinum Toxin Product and Services
7.20.4 Caregen Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Caregen Recent Developments/Updates
7.20.6 Caregen Competitive Strengths & Weaknesses
7.21 Ipsen
7.21.1 Ipsen Details
7.21.2 Ipsen Major Business
7.21.3 Ipsen Dermal Fillers and Botulinum Toxin Product and Services
7.21.4 Ipsen Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Ipsen Recent Developments/Updates
7.21.6 Ipsen Competitive Strengths & Weaknesses
7.22 LIBP
7.22.1 LIBP Details
7.22.2 LIBP Major Business
7.22.3 LIBP Dermal Fillers and Botulinum Toxin Product and Services
7.22.4 LIBP Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 LIBP Recent Developments/Updates
7.22.6 LIBP Competitive Strengths & Weaknesses
7.23 US World Meds
7.23.1 US World Meds Details
7.23.2 US World Meds Major Business
7.23.3 US World Meds Dermal Fillers and Botulinum Toxin Product and Services
7.23.4 US World Meds Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 US World Meds Recent Developments/Updates
7.23.6 US World Meds Competitive Strengths & Weaknesses
7.24 Daewoong
7.24.1 Daewoong Details
7.24.2 Daewoong Major Business
7.24.3 Daewoong Dermal Fillers and Botulinum Toxin Product and Services
7.24.4 Daewoong Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.24.5 Daewoong Recent Developments/Updates
7.24.6 Daewoong Competitive Strengths & Weaknesses
7.25 JETEMA
7.25.1 JETEMA Details
7.25.2 JETEMA Major Business
7.25.3 JETEMA Dermal Fillers and Botulinum Toxin Product and Services
7.25.4 JETEMA Dermal Fillers and Botulinum Toxin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.25.5 JETEMA Recent Developments/Updates
7.25.6 JETEMA Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Dermal Fillers and Botulinum Toxin Industry Chain
8.2 Dermal Fillers and Botulinum Toxin Upstream Analysis
8.2.1 Dermal Fillers and Botulinum Toxin Core Raw Materials
8.2.2 Main Manufacturers of Dermal Fillers and Botulinum Toxin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Dermal Fillers and Botulinum Toxin Production Mode
8.6 Dermal Fillers and Botulinum Toxin Procurement Model
8.7 Dermal Fillers and Botulinum Toxin Industry Sales Model and Sales Channels
8.7.1 Dermal Fillers and Botulinum Toxin Sales Model
8.7.2 Dermal Fillers and Botulinum Toxin Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Dermal Fillers and Botulinum Toxin Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Dermal Fillers and Botulinum Toxin Production Value by Region (2019-2024) & (USD Million)
Table 3. World Dermal Fillers and Botulinum Toxin Production Value by Region (2025-2030) & (USD Million)
Table 4. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Region (2019-2024)
Table 5. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Region (2025-2030)
Table 6. World Dermal Fillers and Botulinum Toxin Production by Region (2019-2024) & (K Units)
Table 7. World Dermal Fillers and Botulinum Toxin Production by Region (2025-2030) & (K Units)
Table 8. World Dermal Fillers and Botulinum Toxin Production Market Share by Region (2019-2024)
Table 9. World Dermal Fillers and Botulinum Toxin Production Market Share by Region (2025-2030)
Table 10. World Dermal Fillers and Botulinum Toxin Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Dermal Fillers and Botulinum Toxin Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Dermal Fillers and Botulinum Toxin Major Market Trends
Table 13. World Dermal Fillers and Botulinum Toxin Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Dermal Fillers and Botulinum Toxin Consumption by Region (2019-2024) & (K Units)
Table 15. World Dermal Fillers and Botulinum Toxin Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Dermal Fillers and Botulinum Toxin Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Dermal Fillers and Botulinum Toxin Producers in 2023
Table 18. World Dermal Fillers and Botulinum Toxin Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Dermal Fillers and Botulinum Toxin Producers in 2023
Table 20. World Dermal Fillers and Botulinum Toxin Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Dermal Fillers and Botulinum Toxin Company Evaluation Quadrant
Table 22. World Dermal Fillers and Botulinum Toxin Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Dermal Fillers and Botulinum Toxin Production Site of Key Manufacturer
Table 24. Dermal Fillers and Botulinum Toxin Market: Company Product Type Footprint
Table 25. Dermal Fillers and Botulinum Toxin Market: Company Product Application Footprint
Table 26. Dermal Fillers and Botulinum Toxin Competitive Factors
Table 27. Dermal Fillers and Botulinum Toxin New Entrant and Capacity Expansion Plans
Table 28. Dermal Fillers and Botulinum Toxin Mergers & Acquisitions Activity
Table 29. United States VS China Dermal Fillers and Botulinum Toxin Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Dermal Fillers and Botulinum Toxin Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Dermal Fillers and Botulinum Toxin Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share (2019-2024)
Table 37. China Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share (2019-2024)
Table 42. Rest of World Based Dermal Fillers and Botulinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share (2019-2024)
Table 47. World Dermal Fillers and Botulinum Toxin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Dermal Fillers and Botulinum Toxin Production by Type (2019-2024) & (K Units)
Table 49. World Dermal Fillers and Botulinum Toxin Production by Type (2025-2030) & (K Units)
Table 50. World Dermal Fillers and Botulinum Toxin Production Value by Type (2019-2024) & (USD Million)
Table 51. World Dermal Fillers and Botulinum Toxin Production Value by Type (2025-2030) & (USD Million)
Table 52. World Dermal Fillers and Botulinum Toxin Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Dermal Fillers and Botulinum Toxin Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Dermal Fillers and Botulinum Toxin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Dermal Fillers and Botulinum Toxin Production by Application (2019-2024) & (K Units)
Table 56. World Dermal Fillers and Botulinum Toxin Production by Application (2025-2030) & (K Units)
Table 57. World Dermal Fillers and Botulinum Toxin Production Value by Application (2019-2024) & (USD Million)
Table 58. World Dermal Fillers and Botulinum Toxin Production Value by Application (2025-2030) & (USD Million)
Table 59. World Dermal Fillers and Botulinum Toxin Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Dermal Fillers and Botulinum Toxin Average Price by Application (2025-2030) & (USD/Unit)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Dermal Fillers and Botulinum Toxin Product and Services
Table 64. AbbVie Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Galderma Basic Information, Manufacturing Base and Competitors
Table 68. Galderma Major Business
Table 69. Galderma Dermal Fillers and Botulinum Toxin Product and Services
Table 70. Galderma Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Galderma Recent Developments/Updates
Table 72. Galderma Competitive Strengths & Weaknesses
Table 73. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 74. LG Life Sciences Major Business
Table 75. LG Life Sciences Dermal Fillers and Botulinum Toxin Product and Services
Table 76. LG Life Sciences Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. LG Life Sciences Recent Developments/Updates
Table 78. LG Life Sciences Competitive Strengths & Weaknesses
Table 79. Merz Basic Information, Manufacturing Base and Competitors
Table 80. Merz Major Business
Table 81. Merz Dermal Fillers and Botulinum Toxin Product and Services
Table 82. Merz Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Merz Recent Developments/Updates
Table 84. Merz Competitive Strengths & Weaknesses
Table 85. Medytox Basic Information, Manufacturing Base and Competitors
Table 86. Medytox Major Business
Table 87. Medytox Dermal Fillers and Botulinum Toxin Product and Services
Table 88. Medytox Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Medytox Recent Developments/Updates
Table 90. Medytox Competitive Strengths & Weaknesses
Table 91. Hugel Basic Information, Manufacturing Base and Competitors
Table 92. Hugel Major Business
Table 93. Hugel Dermal Fillers and Botulinum Toxin Product and Services
Table 94. Hugel Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Hugel Recent Developments/Updates
Table 96. Hugel Competitive Strengths & Weaknesses
Table 97. Croma-Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Croma-Pharma Major Business
Table 99. Croma-Pharma Dermal Fillers and Botulinum Toxin Product and Services
Table 100. Croma-Pharma Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Croma-Pharma Recent Developments/Updates
Table 102. Croma-Pharma Competitive Strengths & Weaknesses
Table 103. Beijing IMEIK Basic Information, Manufacturing Base and Competitors
Table 104. Beijing IMEIK Major Business
Table 105. Beijing IMEIK Dermal Fillers and Botulinum Toxin Product and Services
Table 106. Beijing IMEIK Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Beijing IMEIK Recent Developments/Updates
Table 108. Beijing IMEIK Competitive Strengths & Weaknesses
Table 109. Bloomage Bio Basic Information, Manufacturing Base and Competitors
Table 110. Bloomage Bio Major Business
Table 111. Bloomage Bio Dermal Fillers and Botulinum Toxin Product and Services
Table 112. Bloomage Bio Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Bloomage Bio Recent Developments/Updates
Table 114. Bloomage Bio Competitive Strengths & Weaknesses
Table 115. Elravie (Humedix) Basic Information, Manufacturing Base and Competitors
Table 116. Elravie (Humedix) Major Business
Table 117. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Product and Services
Table 118. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Elravie (Humedix) Recent Developments/Updates
Table 120. Elravie (Humedix) Competitive Strengths & Weaknesses
Table 121. Cleviel (Pharma Research Products) Basic Information, Manufacturing Base and Competitors
Table 122. Cleviel (Pharma Research Products) Major Business
Table 123. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Product and Services
Table 124. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Cleviel (Pharma Research Products) Recent Developments/Updates
Table 126. Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
Table 127. Haohai Biological Basic Information, Manufacturing Base and Competitors
Table 128. Haohai Biological Major Business
Table 129. Haohai Biological Dermal Fillers and Botulinum Toxin Product and Services
Table 130. Haohai Biological Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Haohai Biological Recent Developments/Updates
Table 132. Haohai Biological Competitive Strengths & Weaknesses
Table 133. Teoxane Basic Information, Manufacturing Base and Competitors
Table 134. Teoxane Major Business
Table 135. Teoxane Dermal Fillers and Botulinum Toxin Product and Services
Table 136. Teoxane Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Teoxane Recent Developments/Updates
Table 138. Teoxane Competitive Strengths & Weaknesses
Table 139. Sinclair Basic Information, Manufacturing Base and Competitors
Table 140. Sinclair Major Business
Table 141. Sinclair Dermal Fillers and Botulinum Toxin Product and Services
Table 142. Sinclair Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Sinclair Recent Developments/Updates
Table 144. Sinclair Competitive Strengths & Weaknesses
Table 145. Suneva Medical Basic Information, Manufacturing Base and Competitors
Table 146. Suneva Medical Major Business
Table 147. Suneva Medical Dermal Fillers and Botulinum Toxin Product and Services
Table 148. Suneva Medical Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Suneva Medical Recent Developments/Updates
Table 150. Suneva Medical Competitive Strengths & Weaknesses
Table 151. CG Bio Basic Information, Manufacturing Base and Competitors
Table 152. CG Bio Major Business
Table 153. CG Bio Dermal Fillers and Botulinum Toxin Product and Services
Table 154. CG Bio Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. CG Bio Recent Developments/Updates
Table 156. CG Bio Competitive Strengths & Weaknesses
Table 157. SciVision Biotech Basic Information, Manufacturing Base and Competitors
Table 158. SciVision Biotech Major Business
Table 159. SciVision Biotech Dermal Fillers and Botulinum Toxin Product and Services
Table 160. SciVision Biotech Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. SciVision Biotech Recent Developments/Updates
Table 162. SciVision Biotech Competitive Strengths & Weaknesses
Table 163. Prollenium Basic Information, Manufacturing Base and Competitors
Table 164. Prollenium Major Business
Table 165. Prollenium Dermal Fillers and Botulinum Toxin Product and Services
Table 166. Prollenium Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Prollenium Recent Developments/Updates
Table 168. Prollenium Competitive Strengths & Weaknesses
Table 169. Bohus BioTech Basic Information, Manufacturing Base and Competitors
Table 170. Bohus BioTech Major Business
Table 171. Bohus BioTech Dermal Fillers and Botulinum Toxin Product and Services
Table 172. Bohus BioTech Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Bohus BioTech Recent Developments/Updates
Table 174. Bohus BioTech Competitive Strengths & Weaknesses
Table 175. Caregen Basic Information, Manufacturing Base and Competitors
Table 176. Caregen Major Business
Table 177. Caregen Dermal Fillers and Botulinum Toxin Product and Services
Table 178. Caregen Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Caregen Recent Developments/Updates
Table 180. Caregen Competitive Strengths & Weaknesses
Table 181. Ipsen Basic Information, Manufacturing Base and Competitors
Table 182. Ipsen Major Business
Table 183. Ipsen Dermal Fillers and Botulinum Toxin Product and Services
Table 184. Ipsen Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Ipsen Recent Developments/Updates
Table 186. Ipsen Competitive Strengths & Weaknesses
Table 187. LIBP Basic Information, Manufacturing Base and Competitors
Table 188. LIBP Major Business
Table 189. LIBP Dermal Fillers and Botulinum Toxin Product and Services
Table 190. LIBP Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. LIBP Recent Developments/Updates
Table 192. LIBP Competitive Strengths & Weaknesses
Table 193. US World Meds Basic Information, Manufacturing Base and Competitors
Table 194. US World Meds Major Business
Table 195. US World Meds Dermal Fillers and Botulinum Toxin Product and Services
Table 196. US World Meds Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 197. US World Meds Recent Developments/Updates
Table 198. US World Meds Competitive Strengths & Weaknesses
Table 199. Daewoong Basic Information, Manufacturing Base and Competitors
Table 200. Daewoong Major Business
Table 201. Daewoong Dermal Fillers and Botulinum Toxin Product and Services
Table 202. Daewoong Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 203. Daewoong Recent Developments/Updates
Table 204. JETEMA Basic Information, Manufacturing Base and Competitors
Table 205. JETEMA Major Business
Table 206. JETEMA Dermal Fillers and Botulinum Toxin Product and Services
Table 207. JETEMA Dermal Fillers and Botulinum Toxin Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 208. Global Key Players of Dermal Fillers and Botulinum Toxin Upstream (Raw Materials)
Table 209. Dermal Fillers and Botulinum Toxin Typical Customers
Table 210. Dermal Fillers and Botulinum Toxin Typical Distributors
List of Figure
Figure 1. Dermal Fillers and Botulinum Toxin Picture
Figure 2. World Dermal Fillers and Botulinum Toxin Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Dermal Fillers and Botulinum Toxin Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 5. World Dermal Fillers and Botulinum Toxin Average Price (2019-2030) & (USD/Unit)
Figure 6. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Region (2019-2030)
Figure 7. World Dermal Fillers and Botulinum Toxin Production Market Share by Region (2019-2030)
Figure 8. North America Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 9. Europe Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 10. China Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 11. China Taiwan Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 12. South Korea Dermal Fillers and Botulinum Toxin Production (2019-2030) & (K Units)
Figure 13. Dermal Fillers and Botulinum Toxin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 16. World Dermal Fillers and Botulinum Toxin Consumption Market Share by Region (2019-2030)
Figure 17. United States Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 18. China Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 19. Europe Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 20. Japan Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 21. South Korea Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 22. ASEAN Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 23. India Dermal Fillers and Botulinum Toxin Consumption (2019-2030) & (K Units)
Figure 24. Producer Shipments of Dermal Fillers and Botulinum Toxin by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Dermal Fillers and Botulinum Toxin Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Dermal Fillers and Botulinum Toxin Markets in 2023
Figure 27. United States VS China: Dermal Fillers and Botulinum Toxin Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Dermal Fillers and Botulinum Toxin Production Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Dermal Fillers and Botulinum Toxin Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share 2023
Figure 31. China Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share 2023
Figure 32. Rest of World Based Manufacturers Dermal Fillers and Botulinum Toxin Production Market Share 2023
Figure 33. World Dermal Fillers and Botulinum Toxin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 34. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Type in 2023
Figure 35. Dermal Fillers
Figure 36. Botulinum Toxin
Figure 37. World Dermal Fillers and Botulinum Toxin Production Market Share by Type (2019-2030)
Figure 38. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Type (2019-2030)
Figure 39. World Dermal Fillers and Botulinum Toxin Average Price by Type (2019-2030) & (USD/Unit)
Figure 40. World Dermal Fillers and Botulinum Toxin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Application in 2023
Figure 42. Cosmetic
Figure 43. Medical
Figure 44. World Dermal Fillers and Botulinum Toxin Production Market Share by Application (2019-2030)
Figure 45. World Dermal Fillers and Botulinum Toxin Production Value Market Share by Application (2019-2030)
Figure 46. World Dermal Fillers and Botulinum Toxin Average Price by Application (2019-2030) & (USD/Unit)
Figure 47. Dermal Fillers and Botulinum Toxin Industry Chain
Figure 48. Dermal Fillers and Botulinum Toxin Procurement Model
Figure 49. Dermal Fillers and Botulinum Toxin Sales Model
Figure 50. Dermal Fillers and Botulinum Toxin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
jiaGou

Add To Cart

gouMai

Buy Now